Quarterly report [Sections 13 or 15(d)]

Acquisitions - Narrative (Details)

v3.26.3
Acquisitions - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 22, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Jul. 28, 2026
Jun. 02, 2026
Dec. 31, 2025
Business Combination [Line Items]                
Payments of cash acquired       $ 35,818 $ 65,174      
Goodwill   $ 101,918   $ 101,918       $ 88,210
Common Stock                
Business Combination [Line Items]                
Issuance of common stock in acquisition (in shares)     3,434,609 742,060 3,434,609      
Louisville Perfusion Services                
Business Combination [Line Items]                
Percentage of equity interest acquired             100.00%  
Contingent consideration   2,800   $ 2,800        
Louisville Perfusion Services | Maximum                
Business Combination [Line Items]                
Contingent consideration   4,080   4,080        
Heart and Lung Transplant National Recovery Program                
Business Combination [Line Items]                
Percentage of equity interest acquired 100.00%              
Statline | Maximum                
Business Combination [Line Items]                
Contingent consideration           $ 567    
Individually Immaterial Business Combinations                
Business Combination [Line Items]                
Contingent consideration   3,302   3,302        
Acquisition-related costs expense   64   818        
Total purchase consideration       43,128        
Payments of cash acquired       35,559        
Identifiable intangible assets   23,882   23,882        
Goodwill   $ 15,476   15,476        
Individually Immaterial Business Combinations | Minimum                
Business Combination [Line Items]                
Acquisition-related costs expense $ 500              
Individually Immaterial Business Combinations | Maximum                
Business Combination [Line Items]                
Acquisition-related costs expense $ 22,300              
HLT-NRP                
Business Combination [Line Items]                
Equity consideration       $ 4,267        
HLT-NRP | Common Stock                
Business Combination [Line Items]                
Stock price (in dollars per share) $ 5.75